The global demand for High-Throughput Screening Market is presumed to reach the market size of nearly USD 96.38 BN by 2030 from USD 20.29 BN in 2022 with a CAGR of 21.5% under the study period 2023 - 2030.
High-throughput screening (HTS) is a method used in drug discovery and molecular biology to quickly and efficiently test a large number of chemical compounds or biological molecules for their ability to interact with a target of interest. The goal of HTS is to identify potential drug candidates or biological molecules that can modulate the activity of a specific target, such as a protein or enzyme. HTS involves the use of automated systems, robotics, and advanced data analysis tools to screen thousands or even millions of compounds or molecules in a short period of time. Typically, a large library of compounds or molecules is screened against a target of interest, and the compounds that show promising activity are further evaluated in more detailed studies.
With the growing prevalence of various diseases such as cancer, Alzheimer's disease, and autoimmune disorders, there is an increasing demand for novel drug discovery. HTS enables researchers to screen a large number of compounds rapidly, which helps in identifying potential candidates for drug development. The development of advanced automated screening systems, robotics, and data analysis tools has led to improvements in the efficiency and accuracy of HTS. This has enabled researchers to screen a larger number of compounds more quickly and efficiently, reducing the time and cost of drug discovery. The increasing investments by companies operational in the pharmaceutical and biotechnology field, as well as academic research institutions, have contributed to the growth of the HTS market. The government initiatives for funding research and development activities in the pharmaceutical and biotechnology industries have further contributed to the growth of the HTS market. With the rise of personalized medicine, there is a growing need for targeted drug therapies. HTS plays a crucial role in the development of personalized medicine by enabling the screening of a large number of compounds and identifying the ones that are most effective for a specific patient. The growth in chronic diseases, such as cancer and diabetes, has led to a growing need for new drug therapies. HTS can accelerate the discovery of new drug candidates, making it an important tool in the development of new treatments for chronic diseases.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of high-throughput screening. The growth and trends of high-throughput screening industry provide a holistic approach to this study.
This section of the high-throughput screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product & Service
By Technology
By Application
By End User
This section covers the regional outlook, which accentuates current and future demand for the High-Throughput Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the high-throughput screening market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, PerkinElmer Inc., Tecan Group Ltd., AXXAM S.p.A., Merck KGaA, Bio-Ras Laboratories Inc., Promega Corporation, Corning Incorporated and Eurofins Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Avail customized purchase options to meet your exact research needs: